Radioactive cocktail aims to stall prostate cancer spread
NCT ID NCT00859781
First seen Apr 10, 2026 · Last updated May 24, 2026 · Updated 8 times
Summary
This study tests whether combining a radioactive drug (177Lu-J591) with hormone therapy (ketoconazole) can delay the spread of prostate cancer in men whose PSA is rising despite hormone treatment. The trial includes 55 men with high-risk, non-metastatic prostate cancer. The main goal is to see how many remain free of visible cancer spread on scans for 18 months after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cedars Sinai
Los Angeles, California, 90048, United States
-
Georgetown University Medical Center
Washington D.C., District of Columbia, 20007, United States
-
Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, 46202, United States
-
The University of Kansas Cancer Center
Westwood, Kansas, 66205, United States
-
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
-
USC/Norris Comprehensive cancer center
Los Angeles, California, 90089, United States
-
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
-
University of Utah
Salt Lake City, Utah, 84108, United States
-
Weill Cornell Medical College
New York, New York, 10021, United States
Conditions
Explore the condition pages connected to this study.